Crossmark

Innovative Nanocarriers of Sorafenib in the Optimisation of Therapeutic Outcome: Challenges and Applications in Breast Cancer

Crossref DOI link: https://doi.org/10.1208/s12249-026-03392-9

Published Online: 2026-03-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chaurawal, Nishtha https://orcid.org/0009-0004-6764-8597
Estrada, Amalia Ruiz https://orcid.org/0000-0001-8358-5304
Pors, Klaus https://orcid.org/0000-0002-0837-5208
Raza, Kaisar https://orcid.org/0000-0001-8159-8005
Wahajuddin, Muhammad https://orcid.org/0000-0003-3362-7558
License Information

Text and Data Mining valid from 2026-03-19

Version of Record valid from 2026-03-19
More Information

Article History

Received: 2 December 2025

Accepted: 26 February 2026

First Online: 19 March 2026

Declarations

:

: The authors declare no competing interest.